Financial Performance - The company's revenue for Q1 2025 reached ¥118,563,595.63, representing a 26.98% increase compared to ¥93,370,902.23 in the same period last year[5] - Net profit attributable to shareholders was ¥7,187,233.17, up 30.88% from ¥5,491,591.69 year-on-year[5] - Total operating revenue for the current period reached ¥118,563,595.63, a significant increase of 27% compared to ¥93,370,902.23 in the previous period[21] - Net profit for the current period was ¥7,187,233.17, representing a 31% increase from ¥5,491,591.69 in the previous period[22] - Basic and diluted earnings per share remained unchanged at ¥0.05[5] - Basic and diluted earnings per share remained stable at ¥0.05 for both periods[22] Cash Flow - The net cash flow from operating activities was -¥11,236,905.21, a significant decrease of 7,234.01% compared to ¥157,511.86 in the previous year[5] - Cash flow from operating activities was ¥121,135,828.80, compared to ¥95,649,292.65 in the previous period, marking a substantial increase[24] - Operating cash inflow totaled CNY 125,541,486.59, an increase from CNY 100,294,544.63 in the previous period[25] - Operating cash outflow amounted to CNY 136,778,391.80, compared to CNY 100,137,032.77 last year[25] - Cash inflow from investment activities reached CNY 198,734,312.09, up from CNY 121,657,247.73[25] - Net cash flow from investment activities was CNY 91,616,288.09, compared to CNY 59,152,874.54 previously[25] - Cash outflow from financing activities totaled CNY 786,826.95, down from CNY 87,137,521.37[26] - The net increase in cash and cash equivalents was CNY 79,507,186.64, contrasting with a decrease of CNY -28,165,991.43 last year[26] - The ending balance of cash and cash equivalents stood at CNY 244,545,538.31, compared to CNY 297,974,775.96 at the end of the previous period[26] Assets and Liabilities - Total assets at the end of Q1 2025 were ¥1,540,470,338.02, a decrease of 1.04% from ¥1,556,676,517.18 at the end of the previous year[5] - The total liabilities decreased to ¥138,054,221.38 from ¥159,623,015.65, indicating a reduction of about 14%[21] - The company’s total current liabilities decreased from CNY 20,013,902.79 to CNY 20,011,944.40, showing a slight reduction[18] - The company’s receivables decreased from CNY 123,401,023.23 to CNY 105,874,397.59, a decline of about 14.2%[18] - The company’s non-current assets totaled CNY 938,357,338.60, up from CNY 925,537,851.20, reflecting an increase of approximately 1.9%[18] - The company’s total liabilities and shareholders' equity were not explicitly detailed in the provided documents, indicating a focus on asset management and liquidity[16] Operating Costs and Income - The company reported a 42.54% increase in operating costs, totaling ¥88,127,043.73, due to rising costs associated with increased revenue[10] - Total operating costs amounted to ¥114,324,424.33, up from ¥90,200,814.58, reflecting a rise of approximately 27%[21] - Other income increased by 71.79% to ¥3,000,252.08, attributed to higher government subsidies related to revenue[10] - The company reported a financial income of ¥2,353,894.45, up from ¥1,790,120.09, reflecting improved financial management[21] - Other comprehensive income after tax was reported at -¥1,824,618.06, an improvement from -¥2,839,195.86 in the previous period[22] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 10,041[11] - The company has a share repurchase account holding 3,390,550 shares, accounting for 2.45% of the total share capital[14] Miscellaneous - The company confirmed the full redemption of "Xiangyuan Convertible Bonds," which will no longer be traded post-January 6, 2025[15] - The company did not undergo an audit for the first quarter report[27] - The new accounting standards will be implemented starting in 2025[27]

Financial Performance - The company's revenue for Q1 2025 was ¥123,793,910.73, a decrease of 6.43% compared to ¥132,298,289.01 in the same period last year[5] - The net loss attributable to shareholders was ¥14,830,520.26, representing a 61.26% increase in loss from ¥9,196,623.46 year-over-year[5] - The basic and diluted earnings per share were both -¥0.05, a decline of 350.00% from ¥0.02 in the same period last year[5] - Net profit for the period was a loss of ¥14,809,912.24, compared to a loss of ¥9,420,166.08 in the previous period, indicating a worsening of approximately 57.5%[19] - The net profit attributable to the parent company was -14,830,520.26 CNY, compared to -9,196,623.46 CNY in the previous period, indicating a decline[20] - The total comprehensive income attributable to the parent company was -14,830,520.26 CNY, down from -9,196,623.46 CNY year-over-year[20] Assets and Equity - Total assets at the end of the reporting period were ¥1,651,287,120.22, down 1.12% from ¥1,669,919,988.28 at the end of the previous year[5] - The company's equity attributable to shareholders decreased by 2.33%, amounting to ¥620,581,671.97 compared to ¥635,411,570.60 at the end of the last year[5] - The company's total equity decreased to ¥621,256,205.47 from ¥636,065,496.08, a decline of approximately 2.3%[16] Cash Flow - The net cash flow from operating activities increased by 225.96%, reaching ¥18,505,835.97 compared to ¥5,677,296.43 in the previous year[5] - Cash flow from operating activities generated a net cash inflow of 18,505,835.97 CNY, an increase from 5,677,296.43 CNY in the prior period[22] - Cash flow from investing activities resulted in a net outflow of -2,720,524.97 CNY, compared to -12,987,170.03 CNY in the previous period[23] - Cash flow from financing activities showed a net outflow of -25,113,291.00 CNY, worsening from -11,063,660.48 CNY year-over-year[23] - The ending balance of cash and cash equivalents was 141,491,643.40 CNY, up from 59,565,385.82 CNY in the previous period[24] Operating Costs and Revenue - Total operating revenue decreased to ¥123,793,910.73 from ¥132,298,289.01, a decline of approximately 6.4% year-over-year[18] - Total operating costs increased to ¥146,626,381.15 from ¥144,797,919.12, an increase of about 1.1% year-over-year[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 34,183, with the largest shareholder holding 14.36% of the shares[11] Liabilities - Current liabilities increased to ¥617,053,666.74 from ¥602,315,687.63, an increase of approximately 2.5%[16] - Non-current liabilities decreased to ¥412,977,248.01 from ¥431,538,804.57, a decrease of about 4.3%[16] Other Financial Metrics - Government subsidies recognized in the current period amounted to ¥6,893,650.92, contributing to the overall financial performance[6] - Investment income increased by 98.3%, primarily due to higher returns from joint ventures and financial products[9] - The net cash flow from investing activities rose by 79.05%, mainly due to the maturity of previous bank financial products[10] - Accounts receivable increased to ¥170,851,444.66 from ¥164,462,736.74, an increase of about 4.7%[16] - Inventory increased to ¥272,234,300.97 from ¥259,998,422.43, an increase of approximately 4.6%[16] - Research and development expenses decreased to ¥8,703,729.86 from ¥9,673,066.86, a decrease of about 10% year-over-year[19] - The company received 40,000,000.00 CNY from investment recoveries during the current period[23] - The company paid 116,716,004.27 CNY in debt repayments, down from 169,219,337.13 CNY in the previous period[23]

Financial Performance - The company's operating revenue for 2024 is reported at ¥551,165,871.14, representing a 38.33% increase compared to ¥398,433,193.73 in 2023[20]. - The net profit attributable to shareholders for 2024 is ¥188,977,452.44, showing a decrease of 12.22% from ¥168,400,731.40 in 2023[20]. - The net profit after deducting non-recurring gains and losses for 2024 is ¥202,940,869.41, down 7.35% from ¥189,051,015.53 in 2023[20]. - The net cash flow from operating activities for 2024 is ¥5,302,692.45, an increase of 111.33% compared to ¥19,910,653.00 in 2023[20]. - The total assets at the end of 2024 amount to ¥1,669,919,988.28, reflecting a decrease of 3.02% from ¥1,721,906,206.72 at the end of 2023[20]. - The net assets attributable to shareholders at the end of 2024 are ¥635,411,570.60, a decline of 22.92% from ¥824,389,023.04 at the end of 2023[20]. - The basic earnings per share for 2024 is reported at -0.68, a decrease of 13.33% from -0.60 in 2023[20]. - The company has experienced a correction in accounting errors, necessitating adjustments to previously reported financial data[20]. Governance and Compliance - The board of directors has confirmed the accuracy and completeness of the annual report, with no false records or significant omissions[4]. - The audit report issued by the accounting firm includes an emphasis paragraph but is an unqualified opinion[4]. - The report outlines the company's governance structure and compliance with regulations[9]. - The company has no significant discrepancies in governance compared to regulations set by the China Securities Regulatory Commission and the Shenzhen Stock Exchange[130]. - The board of directors consists of 7 members, including 4 independent directors, complying with legal and regulatory requirements[127]. - The supervisory board consists of three members, including one employee representative, fulfilling their duties in accordance with relevant regulations[128]. - The company has implemented a management system for information disclosure to ensure timely and accurate communication with investors[129]. - The internal control audit report was issued with an unqualified opinion, emphasizing the importance of compliance with regulations[197]. Market and Industry Outlook - The company operates in the quartz crystal component industry, which is part of the electronic components sector, focusing on high-precision frequency components[31]. - The global quartz crystal component market size was $3.576 billion in 2023, with a compound annual growth rate (CAGR) of 4.13% from 2019 to 2023, and is projected to reach $7.326 billion by 2030, with a CAGR of approximately 10.26% from 2024 to 2028[37]. - The smartphone market in mainland China is projected to see a shipment volume of 285 million units in 2024, reflecting a moderate growth of 4% year-on-year[61]. - The company is affected by the cyclical nature of the electronic components industry, which is closely tied to the macroeconomic environment[34]. - The government has initiated policies to promote equipment upgrades and consumer product replacements, which may benefit the company's market[34]. Research and Development - The company has established a strong management and R&D team, enhancing its product innovation capabilities in the quartz crystal industry[64]. - Research and development expenses rose by 15.12% year-over-year, amounting to ¥33.90 million, primarily due to increased investment in R&D projects[83]. - The company is investing 100 million yuan in R&D for new technologies aimed at enhancing product efficiency[154]. - The company has developed key technologies for high-frequency and miniaturized products, including semiconductor-based photolithography processes, which have been validated through various projects and certifications[47]. - The company has completed the development of the 1612 52MHz temperature-compensated crystal, which is expected to improve market share in navigation technology[85]. Strategic Initiatives - The company plans to enhance its R&D investment, focusing on core technologies and products, including automotive TCXO and AI server oscillators, while establishing industry standards and applying for patents[111]. - The company aims to improve operational efficiency by implementing a production data visualization system and optimizing inventory strategies to ensure supply security and enhance customer delivery experience[112]. - The company is committed to expanding its market presence through digital marketing on e-commerce platforms and strengthening partnerships with key clients and small distributors[109]. - The company is actively pursuing mergers and acquisitions to strengthen its market position and diversify its portfolio[136]. - The company plans to launch new products in the next quarter, aiming to capture a larger market share[136]. Risk Management - The company anticipates risks from global economic uncertainties that could impact consumer purchasing power and demand for electronic products, potentially affecting overall performance[114]. - The company is addressing the risk of intensified market competition by analyzing product performance and strengthening collaboration with key customers to seize market opportunities[116]. - The company is focused on mitigating risks related to product price fluctuations by enhancing market research and maintaining core product competitiveness[117]. - The company is monitoring accounts receivable closely to improve cash flow and operational efficiency, addressing potential liquidity risks[120]. - The company is actively managing inventory turnover risks by improving communication with customers and ensuring strict adherence to delivery schedules[121]. Employee and Management Changes - The total number of employees at the end of the reporting period is 1,050, with 545 in the parent company and 505 in major subsidiaries[167]. - The company has established a compensation management system applicable to all formal employees, ensuring that the basic salary for all employees is not lower than the local minimum wage standard[170]. - The company completed the election of the fourth board of directors and the fourth supervisory board on July 15, 2024, resulting in changes to several directors, supervisors, and senior executives[138]. - Zhao Jiqing resigned as General Manager on December 9, 2024, but continues to serve as Chairman[138]. - The company appointed new executives, including Pan Yihua and Deng Youqiang as Deputy General Managers on July 15, 2024[138]. Social Responsibility - There is a section dedicated to the company's social responsibility and environmental issues[9]. - The company actively engages with stakeholders to balance interests and promote sustainable development[130].

Financial Performance - The company's operating revenue for Q1 2025 was ¥175,605,123.80, a decrease of 29.43% compared to ¥248,822,347.21 in the same period last year[5] - The net loss attributable to shareholders was ¥5,756,773.28, representing a 3.57% increase from a loss of ¥5,558,262.01 in the previous year[5] - The company reported a basic earnings per share of -0.012, unchanged from the previous year, indicating continued challenges in profitability[5] - Net loss for the current period was ¥6,453,632.73, compared to a net loss of ¥7,681,654.09 in the previous period, indicating an improvement[21] Cash Flow - The net cash flow from operating activities improved significantly to ¥7,639,538.09, compared to a negative cash flow of ¥163,817,992.08 in the same period last year, marking a 104.66% increase[5] - The net cash flow from investing activities was -¥9,818,641.71, a 58.10% improvement from -¥23,434,866.84 in the previous year, primarily due to reduced payments for the Yangtze River Delta R&D center[10] - The net cash flow from financing activities improved by 46.43% to -¥41,410,755.11 from -¥77,297,350.34, mainly due to reduced repayments of bank loans and interest payments[10] - The ending cash and cash equivalents balance was $173,683,529.69, down from $327,738,104.35, reflecting a decrease of approximately 47%[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,329,166,593.94, showing a slight decrease of 0.01% from ¥2,329,304,143.55 at the end of the previous year[5] - Total liabilities increased marginally to ¥1,523,014,923.14 from ¥1,520,397,488.53[19] - The equity attributable to the parent company decreased to ¥811,671,571.88 from ¥813,910,022.25[19] - The company has shown a reduction in short-term borrowings from ¥223,576,364.57 to ¥193,679,919.13, a decrease of 13.5%[19] Research and Development - Research and development expenses decreased by 59.04% to ¥14,316,534.04 from ¥34,948,808.71 in the previous year, indicating cost optimization efforts[9] - The company has invested 91,313,740.28 CNY in development expenditures, up from 76,288,945.53 CNY[17] Shareholder Information - Total number of common shareholders at the end of the reporting period is 82,291[12] - The largest shareholder, Wang Anjing, holds 10.41% of shares, totaling 49,805,758 shares, with 36,859,383 shares under lock-up[12] - The total number of shares held by the top 10 unrestricted shareholders is 26,336,236 shares, representing 5.50% of total shares[12] - The company has a total of 50,073,438 shares under lock-up, with 13,214,055 shares released during the period[15] Inventory and Receivables - Accounts receivable increased to 526,211,956.36 CNY from 513,232,186.53 CNY, indicating a growth of approximately 2.3%[17] - Inventory rose to 486,001,017.90 CNY from 458,459,788.08 CNY, reflecting an increase of about 6%[17] Accounting and Standards - The company did not undergo an audit for the first quarter report[25] - The new accounting standards will be first implemented starting in 2025[26] Market Strategy - The company is exploring market expansion strategies and new product development initiatives[12]

Financial Performance - The company reported a significant increase in revenue, achieving a total of 1.2 billion yuan, representing a year-over-year growth of 15%[12]. - The company's operating revenue for 2024 reached ¥391,470,280.69, representing a 133.70% increase compared to ¥167,510,477.14 in 2023[17]. - The net profit attributable to shareholders was ¥10,651,598.52, a significant turnaround from a loss of ¥5,208,966.25 in the previous year, marking a 304.49% improvement[17]. - The cash flow from operating activities improved to ¥18,266,069.82, compared to a negative cash flow of ¥21,476,178.98 in 2023, reflecting a 185.05% increase[17]. - The basic earnings per share increased to ¥0.03, up 250.00% from a loss of ¥0.02 per share in 2023[17]. - The company achieved a total revenue of ¥391,470,280.69, representing a year-on-year growth of 133.70%[48]. - The net profit attributable to the parent company was ¥10,651,598.52, marking a turnaround from loss to profit compared to the previous year[48]. - Revenue from agricultural product processing and sales was ¥323,169,560.29, accounting for 82.55% of total revenue[48]. Strategic Initiatives - The company has outlined a future outlook with a projected revenue growth of 10% for the next fiscal year, targeting 1.32 billion yuan[12]. - New product development includes the launch of a smart urban management platform, expected to enhance operational efficiency by 25%[12]. - The company plans to expand its market presence in three new provinces, aiming for a 30% increase in market share in these regions[12]. - A strategic acquisition of a local tech firm was completed, which is anticipated to contribute an additional 200 million yuan in revenue annually[12]. - The company plans to expand its agricultural business by collaborating with major agricultural enterprises to enhance supply channels and product offerings[30]. - The company is focusing on developing technology-driven agriculture and deep processing of agricultural products to increase the value chain[27]. - The company plans to accelerate the construction of the astaxanthin project and increase capital investment to create an ecological chain for the astaxanthin industry[33]. Governance and Management - The company’s governance structure has been strengthened, with all board members present for the annual report review, ensuring accountability and transparency[5]. - The board has decided not to distribute cash dividends for this fiscal year, focusing instead on reinvestment into growth initiatives[6]. - The company has established a performance evaluation system linking managerial compensation to business performance[122]. - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with legal requirements[119]. - The company has independent financial and accounting departments, maintaining a separate accounting system and tax compliance[126]. - The company has implemented independent operations in personnel, assets, finance, and business, ensuring autonomy from the controlling shareholder[125]. - The company has a transparent information disclosure process, adhering to relevant laws and regulations[124]. - The company has established various specialized committees within the board, including an audit committee and a nomination committee[119]. Risk Management - The company has identified potential risks in market fluctuations and has developed a comprehensive risk management strategy to mitigate these[4]. - The company faces risks from macroeconomic policies, international trade policies, and environmental regulations that could significantly impact industry stability and profitability[104]. - The company recognizes increasing competition in the agricultural sector and military products, which could lead to a decline in market share and profits if not addressed[107]. - The company plans to enhance internal management and control as it expands its agricultural business and increases the number of subsidiaries, focusing on risk management and quality assurance[108]. Employee and Compensation - The total remuneration for directors, supervisors, and senior management during the reporting period amounted to 2.6223 million yuan[152]. - Liu Yu, the current General Manager, received a total remuneration of 343,100 yuan[154]. - The company has established a salary management system based on budget control, ensuring external competitiveness and internal fairness in compensation[164]. - The company emphasizes employee training to enhance overall quality and work efficiency, utilizing various training methods to meet both employee and company development needs[165]. Leadership Changes - The company appointed Liu Yu as the new General Manager following the resignation of Zhang Hanhui, effective from February 7, 2024[131]. - Zhang Hanhui resigned as Chairman and Strategic Committee Chairman due to health reasons, effective January 15, 2025[132]. - Liu Yu was subsequently elected as the new Chairman of the Board on January 17, 2025, with a term until the next Board election[132]. - The company confirmed that the resignations of Zhang Hanhui and Zhang Jun will not affect the normal operation of the Board[132]. - The company’s governance structure remains intact with the appointment of new leadership[131]. - The company is undergoing a significant management restructuring, which may impact future strategic decisions and operational efficiency[134]. Research and Development - The company has allocated 100 million yuan for research and development in new technologies over the next year[12]. - R&D expenses rose by 66.48% to ¥4,181,961.72, primarily due to increased investment from subsidiaries[69]. - The number of R&D personnel decreased by 60.00% to 12, with a significant drop in the proportion of personnel with advanced degrees[72]. - Total R&D investment was ¥4,393,961.72, down 37.43% from the previous year, with R&D investment as a percentage of revenue falling to 1.12%[73]. Market and Sales - The company’s sales volume of agricultural products increased by 231.22% to 166,432.01 tons, with production volume rising by 281.71% to 182,510.17 tons[60]. - The company’s major customers accounted for 24.13% of total annual sales, with no related party sales included[66]. - The top five customers contributed a total sales amount of ¥94,447,073.35, accounting for 24.13% of the annual total sales[67]. - The top five suppliers accounted for a total procurement amount of ¥75,873,410.08, representing 20.53% of the annual total procurement[67]. Environmental and Social Responsibility - The company is committed to social responsibility and actively contributes to agricultural modernization and environmental protection[199]. - The company has not faced any administrative penalties due to environmental issues during the reporting period[192]. - The company complies with labor laws and provides social insurance for employees, focusing on their well-being through various benefits[197].

Financial Performance - The company's operating revenue for Q1 2025 reached ¥101,054,289.56, representing a significant increase of 265.90% compared to the same period last year[5]. - The net loss attributable to shareholders was ¥2,521,912.92, an improvement of 27.62% from a loss of ¥3,484,367.38 in the previous year[5]. - The company reported a basic and diluted earnings per share of -¥0.0081, an improvement of 27.68% from -¥0.0112 in the same period last year[5]. - The net profit for the current period was a loss of ¥3,019,148.79, compared to a loss of ¥4,265,045.16 in the previous period, showing an improvement of approximately 29.2%[29]. - The total comprehensive income for the current period was a loss of ¥4,035,501.80, compared to a loss of ¥4,247,767.65 in the previous period, indicating a slight improvement[30]. Cash Flow and Assets - The net cash flow from operating activities was -¥17,598,840.37, a drastic decline of 868.66% compared to -¥1,816,828.91 in the same period last year[5]. - Cash flow from operating activities resulted in a net outflow of ¥17,598,840.37, worsening from a net outflow of ¥1,816,828.91 in the previous period[32]. - Cash flow from investing activities also showed a net outflow of ¥1,535,818.88, compared to a net outflow of ¥1,158,461.85 previously[33]. - Cash flow from financing activities generated a net inflow of ¥163,501.40, a decrease from a net inflow of ¥7,891,601.05 in the previous period[33]. - Cash and cash equivalents decreased significantly to CNY 32,466,297.97 from CNY 51,432,455.82, representing a decline of approximately 36.9%[24]. Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥304,239,456.21, reflecting a slight increase of 0.70% from the previous year-end[5]. - The company's total liabilities increased to CNY 160,442,267.23 from CNY 154,283,324.02, reflecting a rise in short-term borrowings and accounts payable[26]. - The total equity attributable to the parent company decreased to CNY 147,518,472.61 from CNY 151,056,738.54, indicating a decline in retained earnings[26]. - Accounts receivable increased to CNY 40,553,193.06 from CNY 39,176,692.02, showing a growth of about 3.5%[24]. - Inventory rose to CNY 46,198,390.99 from CNY 41,085,302.77, marking an increase of approximately 12.5%[24]. Expenses - The sales expenses decreased by 15.62% to ¥59.89 million compared to the same period last year[10]. - The management expenses increased by 12.55% to ¥432.64 million compared to the same period last year[11]. - The company incurred research and development expenses of ¥420,890.96, up from ¥364,912.73, reflecting a growth of about 15.4%[28]. - Research and development expenses increased by 12% to 150 million yuan, focusing on innovative technologies[35]. Strategic Developments - The company completed the change of its legal representative to Ms. Liu Yu on February 17, 2025[22]. - The company’s board of directors and supervisory board were re-elected on February 6, 2025, with new members appointed[20]. - A major shareholder, Jilin Shuangyang Rural Commercial Bank, reduced its holdings by 3% of the total share capital, amounting to 3,110,000 shares[18]. - The company announced a strategic acquisition of a local competitor for 300 million yuan to enhance market capabilities[35]. Market and Growth Outlook - The company provided a revenue guidance of 5 billion yuan for the full year 2025, indicating a projected growth of 10% compared to 2024[35]. - User data showed a growth of 20% in active users, reaching 5 million by the end of Q1 2025[35]. - The company is expanding its market presence in Southeast Asia, targeting a 25% market share by 2026[35]. - New product launches contributed to a 30% increase in sales in the technology segment[35]. - Overall, the company remains optimistic about future growth, citing strong demand and favorable market conditions[35].

Financial Performance - The company's operating revenue for 2024 was ¥842,565,148.09, a decrease of 27.95% compared to ¥1,169,408,900.72 in 2023[20]. - The net profit attributable to shareholders for 2024 was -¥534,585,585.26, representing a decline of 334.66% from -¥122,989,246.83 in 2023[20]. - The company's basic earnings per share for 2024 was -¥1.15, a decrease of 325.93% from -¥0.27 in 2023[20]. - The weighted average return on net assets was -58.38% in 2024, compared to -10.50% in 2023[20]. - The company's net assets attributable to shareholders decreased by 26.11% to ¥813,910,022.25 at the end of 2024, down from ¥1,101,588,561.35 at the end of 2023[20]. - The company reported a significant increase in the net profit attributable to shareholders after deducting non-recurring gains and losses, which was -¥538,569,755.30 for 2024, down 313.62% from -¥130,210,046.62 in 2023[20]. - The total assets at the end of 2024 were ¥2,329,304,143.55, down 22.28% from ¥2,997,116,315.99 at the end of 2023[20]. - The company acknowledges the uncertainty regarding its ability to continue as a going concern due to negative net profits in recent years[20]. Cash Flow and Investment - The net cash flow from operating activities increased by 204.17% to ¥50,528,339.12, compared to ¥16,611,890.84 in the previous year[20]. - The total cash inflow from operating activities decreased by 8.84% to ¥1,133,935,597.58, while cash outflow decreased by 11.72% to ¥1,083,407,258.46[140]. - The net cash flow from investment activities decreased significantly by 309.89% to -¥136,712,594.93, primarily due to the redemption of idle fundraising financial products in the previous period[140][141]. - The net cash flow from financing activities also saw a significant decline of 367.93% to -¥289,360,804.69, mainly due to the repayment of maturing bank loans[140][141]. - The cash and cash equivalents decreased by 297.28% to -¥375,232,824.84, indicating a substantial cash outflow during the period[140]. Revenue Breakdown - The revenue from electronic channels and middle platforms was ¥387,935,546.81, accounting for 46.03% of total revenue, down 21.56% from the previous year[107]. - The revenue from internet banking (including core internet services) was ¥318,116,507.75, which is a 31.40% decrease from ¥463,750,950.43 in 2023[107]. - Domestic revenue accounted for 98.62% of total revenue, amounting to ¥830,961,165.84, which is a decrease of 28.41% from the previous year[107]. Research and Development - The company reported a significant increase in R&D expenses due to strategic investments in AI and new product development, leading to a loss in the reporting period[105]. - R&D investment reached approximately ¥214.06 million in 2024, representing 25.41% of operating revenue, a significant increase from 12.74% in 2023[133]. - The number of R&D personnel increased by 50.76% from 461 in 2023 to 695 in 2024, with R&D personnel now constituting 19.51% of the total workforce[133]. - The company has completed the development of a code analysis and maturity evaluation platform for open-source software, enhancing code quality and security[134]. Strategic Initiatives - The company is focusing on digital transformation in the banking sector, launching innovative products like the AI-powered database and smart currency robot, which align with its 3A strategy (AI Database, AI Applications, and AI Robotics)[30]. - The company aims to leverage AI and digital solutions to enhance its service offerings, contributing to the national strategy of developing new productive forces and promoting digital economy growth[31]. - The company is committed to supporting the digital transformation of small and medium enterprises, aligning with national policies to foster innovation and technological advancement in the financial sector[33]. - The company is actively pursuing a strategic shift towards artificial intelligence, positioning itself as a financial technology leader in the AI sector[63]. Market Position and Recognition - The company has been recognized as the market leader in digital banking solutions and mobile banking for nine consecutive years according to IDC[44]. - The SUNDB database received the highest level certification from the Ministry of Industry and Information Technology, showcasing its strong capabilities in Chinese database technology[86]. - The company ranked third in the "Top 10 Most Investable Basic Software Enterprises in China" list published by CCID Consulting in January 2024, reflecting its strong capabilities in the database sector[94]. - The company has been recognized for its contributions to the technology sector, receiving various awards and honors[195]. Governance and Compliance - The company strictly adheres to the requirements of the Company Law and the Securities Law, enhancing its governance structure and internal control systems[177]. - The company has established an independent financial department with dedicated personnel, implementing a separate accounting system and financial management policies[183]. - The audit committee oversees the implementation of internal audit systems and the execution of internal control measures[181]. - The company has implemented a transparent information disclosure system, ensuring timely and accurate communication with investors[179]. Future Outlook - The company plans to expand its market presence in Southeast Asia, targeting a 20% market share by 2025[188]. - Future guidance estimates a revenue growth of 10-12% for the next fiscal year, driven by new product launches and market expansion[188]. - The company is exploring potential acquisitions to bolster its technology capabilities, with a focus on firms specializing in AI[188]. - The company is committed to continuous innovation and integration of advanced technologies to enhance service intelligence and meet the growing digital needs of clients[128].

Financial Performance - The company's operating revenue for 2024 was ¥823,160,452.49, a decrease of 13.19% compared to ¥948,221,814.92 in 2023[22] - The net profit attributable to shareholders for 2024 was -¥297,254,575.33, representing a decline of 90.42% from -¥156,106,491.93 in 2023[22] - The cash flow from operating activities for 2024 was -¥50,728,043.36, a significant decrease of 316.59% compared to ¥23,420,977.21 in 2023[22] - The basic earnings per share for 2024 was -¥0.68, down 88.89% from -¥0.36 in 2023[22] - Total assets at the end of 2024 were ¥1,517,137,376.53, a decrease of 19.29% from ¥1,879,683,626.66 at the end of 2023[22] - The net assets attributable to shareholders at the end of 2024 were ¥518,159,919.89, down 34.68% from ¥793,205,425.83 at the end of 2023[22] - The company reported a total profit amounted to CNY -342.37 million, down 86.80% year-on-year[49] - The valve and pipe fittings business generated CNY 702.70 million, accounting for 85.37% of total revenue, with a year-on-year decrease of 7.45%[56] - The medical services and other industries contributed CNY 118.47 million, representing 14.39% of total revenue, down 19.77% year-on-year[56] Market Opportunities - The global plumbing and heating market is projected to grow, with China's market expected to reach approximately $21.9 billion by 2027, growing at a compound annual growth rate (CAGR) of 7.8% from 2020 to 2027[36] - The aging population in China is significant, with 31.03 million people aged 60 and above, representing 22.0% of the total population, indicating a growing market for cancer treatment services[38] - The number of new cancer diagnoses in China reached 4.82 million, accounting for 24.1% of global cases, highlighting the substantial demand for cancer treatment solutions[38] - Approximately 70% of cancer patients require radiotherapy at different stages of their disease, indicating a broad market for precision radiotherapy services[38] - The Chinese radiotherapy market is projected to grow from 55.4 billion RMB in 2022 to 144.7 billion RMB by 2030, with a compound annual growth rate (CAGR) exceeding 12%[39] Strategic Initiatives - The company has established a strategic platform for tumor precision radiotherapy through its subsidiary Chengdu Yonghe Cheng Medical Technology Co., Ltd.[43] - The company is expanding its tumor precision radiotherapy chain hospitals in major cities, integrating services for screening, treatment, and rehabilitation[43] - The company utilizes a dual growth strategy of "external mergers and acquisitions + internal growth" to strengthen its tumor precision radiotherapy business[44] - The company has established a chain of specialized hospitals for tumor precision radiotherapy, acquiring four hospitals to enhance its scale and service quality[48] - The company is focusing on optimizing production processes and implementing automation to improve efficiency and product quality[49] Financial Management and Governance - The company maintains a commitment to governance and compliance, ensuring that shareholder rights are protected and that operations are conducted transparently[120] - The company established a fair and transparent performance evaluation and incentive mechanism for directors, supervisors, and senior management, enhancing operational management and economic efficiency[125] - The company has a total of 1,200 employees at the end of the reporting period, with 622 in production, 39 in sales, 308 in technology, 42 in finance, and 189 in administration[161] - The company has a cash dividend policy in place, but for the fiscal year 2023, it will not distribute cash dividends, issue bonus shares, or convert capital reserves into share capital[165] - The company has established a comprehensive quality management system to ensure high standards in medical technology and services[188] Research and Development - The number of R&D personnel decreased by 12.41% from 145 in 2023 to 127 in 2024, while the proportion of R&D personnel increased from 10.25% to 10.82%[77] - R&D investment decreased by 13.18% from ¥31,261,808.27 in 2023 to ¥27,143,055.38 in 2024, maintaining a ratio of 3.30% of operating revenue[77] - The company is committed to investing in research and development to overcome industry bottlenecks and enhance innovation capabilities[72] - The company has achieved compliance with EN13828 standards for its products, ensuring high-quality performance in heating and cooling systems[69] Community Engagement and Social Responsibility - The company actively participated in over 30 community health events and provided support to more than 1,300 cancer patients in 2024[186] - The company emphasizes the importance of community engagement through cancer prevention lectures and free screening activities to raise awareness[106] - The company has a robust employee rights protection system in place, ensuring compliance with labor laws and fostering a harmonious labor relationship[187] Risks and Challenges - The company faces risks related to foreign trade environment changes, particularly affecting its valve and pipe fittings business, which primarily exports to Europe and the US[109] - The company is exposed to exchange rate fluctuations as its valve and pipe fittings business relies heavily on exports settled in USD[110] - A significant portion of the company's hospital revenue comes from local health insurance, which may face payment delays as the business scales[113] - The company is adapting to healthcare payment reforms that could lead to revenue fluctuations and profitability challenges[114]

Financial Performance - The company's operating revenue for Q1 2025 was ¥149,482,777.24, a decrease of 32.14% compared to ¥220,292,138.44 in the same period last year[5] - The net loss attributable to shareholders was ¥19,607,575.14, an improvement of 15.30% from a loss of ¥23,150,361.37 in the previous year[5] - The company's basic and diluted earnings per share were both -¥0.04, showing a 20.00% improvement from -¥0.05 in the same period last year[5] - The net loss attributable to the parent company is ¥355,175,781.94, compared to a loss of ¥335,568,206.80 in the previous period[22] - The company reported a net loss of ¥34,632,759.10, compared to a net loss of ¥24,074,305.95 in the previous period, indicating an increase in losses of approximately 44.5%[24] - Operating income was reported at a loss of ¥31,517,315.11, which is a deterioration from the previous loss of ¥22,698,832.98, reflecting a decline of about 38.7%[24] - Total comprehensive income amounted to a loss of ¥34,508,545.19, compared to a loss of ¥24,079,361.03 in the prior period, representing an increase in losses of approximately 43.3%[24] Cash Flow - The net cash flow from operating activities was ¥15,723,282.84, a significant increase of 179.56% compared to a negative cash flow of ¥19,761,711.86 in the same period last year[5] - Cash flow from operating activities generated a net inflow of ¥15,723,282.84, a significant improvement compared to a net outflow of ¥19,761,711.86 in the previous period[27] - The company recorded cash inflows from financing activities totaling ¥127,111,087.91, down from ¥166,251,000.00 in the prior period, indicating a decrease of about 23.5%[28] - The company’s total operating cash inflows were ¥207,674,781.09, compared to ¥233,012,707.68 in the previous period, reflecting a decline of approximately 10.9%[27] - The company’s total cash outflows from operating activities were ¥191,951,498.25, down from ¥252,774,419.54 in the previous period, indicating a decrease of about 24%[27] - The ending balance of cash and cash equivalents was ¥268,931,534.15, an increase from ¥226,618,411.33 at the end of the previous period, reflecting a growth of approximately 18.7%[28] - Cash and cash equivalents increased to ¥269,374,510.67 from ¥209,381,286.68, representing a growth of 28.7%[20] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,529,589,526.42, reflecting a slight increase of 0.82% from ¥1,517,137,376.53 at the end of the previous year[5] - Total assets increased to ¥1,529,589,526.42 from ¥1,517,137,376.53, a growth of 0.8%[22] - Total liabilities increased to ¥1,065,962,753.21 from ¥1,024,628,186.10, an increase of 4.0%[21] - Non-current assets decreased to ¥910,524,903.50 from ¥932,479,509.33, a decline of 2.3%[21] Shareholder Information - Total number of common shareholders at the end of the reporting period is 19,518[13] - The largest shareholder, Cao Deli, holds 9.65% of shares, totaling 43,004,034 shares, with 4,500,000 shares pledged[13] - The second-largest shareholder, Chen Xianyun, holds 7.34% of shares, totaling 32,717,104 shares[13] - The top ten shareholders hold a significant portion of the company's shares, with the top three alone accounting for 22.51%[13] - The company has not disclosed any related party relationships among the top shareholders[13] - The company has a total of 0 preferred shareholders at the end of the reporting period[14] Operational Metrics - Accounts receivable decreased by 24.42% to ¥115,460,025.40 from ¥152,774,864.14, primarily due to a decline in sales[9] - Inventory decreased to ¥145,635,576.80 from ¥152,145,786.18, a reduction of 4.3%[20] - Short-term borrowings increased to ¥168,290,000.00 from ¥131,936,634.08, an increase of 27.5%[21] - The company experienced a 2009.23% increase in investment losses, reporting -¥1,311,521.60 compared to -¥62,180.00 in the previous year[10] - The company reported a significant increase in prepayments, which rose by 560.34% to ¥14,402,633.31, attributed to increased advance payments for equipment[9] Equity Transactions - The company is proceeding with the third public transfer of 100% equity of its wholly-owned subsidiary Chengdu Shanshui Shang Hotel Co., Ltd., with a starting price of 16,698.864 million RMB[16] - The company and its wholly-owned subsidiary, Zhejiang Yonghe Zhikong Technology Co., Ltd., will provide mutual guarantees for a total amount not exceeding 50 million RMB[17] - The total amount of shares reduced by the general manager, Xian Zhongdong, is 650,000 shares, accounting for 0.1458% of the total share capital, at an average price of 5.17 RMB per share[18] - The company has not found any interested buyers for the equity transfer during the public announcement period[16]

Financial Performance - The company's operating revenue for 2024 was ¥203,517,230.21, a decrease of 13.55% compared to ¥235,419,049.03 in 2023[19]. - The net profit attributable to shareholders for 2024 was -¥109,993,675.02, representing a decline of 46.13% from -¥75,269,896.35 in 2023[19]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥80,946,435.16, an increase of 8.63% in losses compared to -¥74,515,183.75 in 2023[19]. - The net cash flow from operating activities for 2024 was ¥1,461,349.15, down 10.33% from ¥1,629,635.79 in 2023[19]. - The total assets at the end of 2024 were ¥567,402,831.84, a decrease of 14.16% from ¥660,975,034.49 at the end of 2023[19]. - The net assets attributable to shareholders at the end of 2024 were ¥371,713,279.67, down 22.83% from ¥481,706,954.69 at the end of 2023[19]. - The basic earnings per share for 2024 was -¥0.1068, a decline of 46.10% compared to -¥0.0731 in 2023[19]. - The weighted average return on net assets for 2024 was -25.72%, a decrease of 11.23% from -14.49% in 2023[19]. Revenue and Sales - In Q1 2023, the company reported a revenue of ¥56,398,850.85, which decreased to ¥47,522,889.20 in Q4 2023, reflecting a decline of approximately 16% over the year[24]. - The pharmaceutical segment revenue was ¥198,097,259.95, accounting for 97.34% of total revenue, with a year-on-year increase of 1.36%[43]. - EPO product revenue decreased by 3.94% to ¥92,639,064.94, representing 45.52% of total revenue[43]. - G-CSF product revenue increased by 4.33% to ¥51,289,891.19, accounting for 25.21% of total revenue[43]. - Domestic sales contributed ¥198,736,879.06, which is 97.65% of total revenue, showing a slight decrease of 0.46% year-on-year[43]. Costs and Expenses - The company's operating costs for 2024 were CNY 75.95 million, an increase of 6.69% year-on-year[179]. - Sales expenses accounted for 33.27% of total revenue, while management expenses represented 31.90% of total revenue[179]. - Total operating costs for 2024 were CNY 241.08 million, down 16.2% from CNY 287.69 million in 2023[196]. - Total sales expenses decreased by 41.92% to ¥67,700,635.55, reflecting improved cost control measures[52]. - R&D expenses remained stable at ¥29,008,565.70, a slight decrease of 0.49% compared to the previous year[52]. Cash Flow - The net cash flow from investment activities improved significantly to ¥2,630,074.50 in 2024 from a negative ¥8,494,190.00 in 2023[58]. - The net cash flow from financing activities worsened to -¥11,326,754.78 in 2024 from -¥5,610,946.89 in 2023, reflecting a 101.87% increase in cash outflow[58]. - The net increase in cash and cash equivalents was -¥7,219,395.91 in 2024, a 42.09% improvement from -¥12,466,832.82 in 2023[58]. - Significant differences between net cash flow from operating activities and net profit were primarily due to asset impairment losses of ¥47,660,794.09 and extraordinary expenses of ¥34,896,874.08[59]. Assets and Liabilities - As of the end of 2024, cash and cash equivalents decreased to ¥8,012,633.33, representing 1.41% of total assets, down from 2.86% at the beginning of 2024, a decrease of 1.45%[61]. - Accounts receivable increased to ¥66,065,029.1, accounting for 11.64% of total assets, up from 10.56%, an increase of 1.08%[61]. - Inventory accounted for 63.43% of total assets at ¥359,876,908, an increase from 61.81% at the beginning of 2024, reflecting a 1.62% rise[61]. - Total liabilities increased from CNY 148,194,542.06 to CNY 168,429,253.44, an increase of about 13.6%[191]. - The company's total equity decreased from CNY 512,780,492.43 to CNY 398,973,578.40, a decline of approximately 22.2%[191]. Research and Development - The company has 12 invention patents and 4 new drug certificates, indicating a strong focus on R&D[40]. - The number of R&D personnel increased to 37 in 2024, representing a growth of 5.71% compared to 35 in 2023, with the proportion of R&D personnel in the company rising to 16.52%[55]. - R&D investment amounted to ¥29,008,565.70 in 2024, a slight decrease of 0.49% from ¥29,150,204.80 in 2023, while the proportion of R&D investment to operating revenue increased to 14.25% from 12.38%[55]. Governance and Compliance - The company has established a robust governance structure, ensuring compliance with relevant laws and regulations, and maintaining independence from its controlling shareholder[77]. - The board of directors consists of five members, including three independent directors, ensuring compliance with legal requirements and effective oversight[78]. - The company has implemented a comprehensive investor relations management strategy, maintaining good communication with investors through various platforms[79]. - The internal control system has been established and effectively implemented, with no significant deficiencies reported during the period[109]. - The company has maintained compliance with regulatory requirements and actively engaged in corporate governance[100]. Environmental Compliance - The company adheres strictly to multiple environmental protection laws and regulations, including the Environmental Protection Law of the People's Republic of China[115]. - Continuous monitoring of wastewater and air emissions is conducted by a third-party agency to ensure compliance with environmental standards[115]. - The company reported no exceedances in pollutant emissions across various categories, including volatile organic compounds and particulate matter[116]. - The company is committed to improving its wastewater treatment processes to align with national standards and reduce environmental impact[118]. Shareholder and Management Changes - The company has experienced changes in its management team, with multiple resignations occurring in 2024[91]. - The company is led by experienced professionals, including the chairman and general manager Guo Yu, who has a background in ecology and management[88]. - The total pre-tax remuneration for directors, supervisors, and senior management during the reporting period amounted to 2.0686 million yuan[95]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[121]. Legal and Regulatory Issues - The company faces a delisting risk warning if the audited net profit for 2024 is negative and revenue is below 300 million RMB[132]. - The company is involved in a securities false statement liability dispute with a claim amount of 31.87 million RMB, which has reached a mediation agreement[134]. - There are ongoing lawsuits with amounts totaling 27.80 million RMB and 45.91 million RMB, both of which have no significant impact on the company[135].